News
- Author:
- Amy Karon
Publish date: May 15, 2019
The correlation was strongest for onset by age 10 years.
News
- Author:
- Amy Karon
Publish date: May 8, 2019
An ustekinumab trough level of 2.0 mcg/mL or higher distinguished responders from nonresponders with an area under the receiver operating curve of ...
News
- Author:
- Amy Karon
Publish date: May 8, 2019
Multiple clock genes showed reduced mRNA expression in inflamed and uninflamed intestinal mucosa and peripheral white blood cells from patients, co...
News
- Author:
- Amy Karon
Publish date: May 8, 2019
For patients listed for liver transplantation, determine timing of DAA therapy on a case-by-case basis, consider regional wait times, availability ...
News
- Author:
- Amy Karon
Publish date: May 1, 2019
Significantly greater improvements in physical and social activities were seen with both ulipristal doses, compared with placebo, from baseline to ...
News
- Author:
- Amy Karon
Publish date: May 1, 2019
Cumulative rates of flare at 1 year were 33% with initial tapering of conventional synthetic DMARDs and 43% with initial TNF-inhibitor tapering (
News
- Author:
- Amy Karon
Publish date: May 1, 2019
An ustekinumab trough level of 2.0 mcg/mL or higher distinguished responders from nonresponders with an area under the receiver operating curve of ...
News
- Author:
- Amy Karon
Publish date: April 30, 2019
Keys to success included providing recipes and meal planners, education on how lifestyle and diet contribute to NAFLD, and offering care in person,...
News
- Author:
- Amy Karon
Publish date: April 30, 2019
In all, 12.4% of patients had a positive screen for possibly undiagnosed psoriatic arthritis but had never been diagnosed with the disease.
News
- Author:
- Amy Karon
Publish date: April 23, 2019
In the phase 1/2 study, seven infants had normal immune cells 3-4 months after treatment, while the eighth infant responded after a gene therapy bo...
News
- Author:
- Amy Karon
Publish date: April 9, 2019
Fully 75% of PPI nonresponders had concurrent functional heartburn or reflux hypersensitivity.
News
- Author:
- Amy Karon
Publish date: April 9, 2019
The iCureCeliac Patient Powered Research Network is supported by the Patient-Centered Outcomes Research Institute. The investigators reported havin...
News
- Author:
- Amy Karon
Publish date: April 1, 2019
MIAMI – TMAO alters cholesterol and bile acid metabolism, upregulates inflammatory pathways, and promotes foam cell formation, all of which worsen ...
News
- Author:
- Amy Karon
Publish date: April 1, 2019
Aminosalicylates, biologics, and immunomodulators can be continued during pregnancy and delivery.
News
- Author:
- Amy Karon
Publish date: April 1, 2019
Two large studies have found switching to be safe, but FDA has not designated any biosimilar interchangeable.
